Icon

DEFENCATH (NDA214520)- (3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML),5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML))

HEPARIN SODIUM; TAUROLIDINE CORMEDIX
3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML),5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML)
No No
2042-Apr-15 2028-Nov-15
None None
None No
DEFENCATH is a combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant, indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.
0 0 0
Total Other Developers None
Drugs with Suitability No
3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML) ** ** - - -
5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.